Aequs is genuinely two businesses under one roof. Its aerospace segment — Tier-1 relationships with Airbus, Boeing, Safran and Collins Aerospace, an order book that crossed US$1.0 billion in June 2026, and ₹731 million of Q1 FY27 EBITDA — is real, profitable, and growing (+40% YoY that quarter). Its Consumer segment (electronics, plastics, toys, cookware) is nearly tripling revenue (+190% YoY) but lost ₹361 million in the same quarter, dragged down by a slower-than-planned ramp of its Advanced Technology Product facility.
The combination produced a consolidated net loss in every year shown, FY23 through FY26, and CARE Ratings — while recently upgrading its outlook to Positive — still rates Aequs BBB-, a sub-investment- grade-adjacent level reflecting exactly this dynamic. Management's own targets (Consumer EBITDA breakeven by Q4 FY27, consolidated PAT breakeven by H1 FY28) are specific and checkable, but not yet achieved.
Nine months into public trading (IPO: 10 December 2025), with 99% of promoter shares still locked in, this is simply too early a stage to rate with high confidence in either direction. The aerospace core alone would likely support a positive view; the Consumer segment's unproven economics are the reason this stays at HOLD rather than BUY.
Aequs is a full main-board listed company under standard SEBI LODR obligations following its December 2025 IPO.
The board is a six-member board with three independent directors (50%, meeting the SEBI minimum for a non-independent, executive Chairman). Statutory auditor B S R & Co. LLP delivered an unmodified review opinion on the most recent quarterly results. When a listing-linked management bonus became payable on the actual IPO completion, the Executive Chairman & CEO voluntarily waived it — a genuinely positive, self-correcting governance action, not something this report had to surface through adversarial digging.
No PE-nominee directors sit on the board despite a disclosed history of substantial CCPS-based private equity funding (~₹586cr in FY23/24) — notable given the scale of that capital, though not inherently improper. The named PE backers this research was asked to verify (Amazon, A91 Partners, Positive Sum) could not be located in the current shareholding pattern, leaving their current involvement, if any, unclear.
None found beyond the already-resolved listing-bonus item. No litigation or SEBI enforcement action was located in the sources reviewed. We note this reflects the documents reached, not an exhaustive legal-database search — appropriate caution for a company only nine months into public trading.
Consumer segment's progress toward the stated Q4 FY27 EBITDA-breakeven target; the credit rating's next review given the current Positive outlook; clarification of the pre-IPO PE investors' current holding structure, if any; the lock-in expiry schedule as it approaches.
Good early signs, appropriately caveated by a very short public track record. The voluntary bonus waiver is a genuinely positive signal; the unconfirmed PE-backer question and the absence of any PE-nominee board seats are open items worth resolving, not treated as settled either way.
With the company loss-making at the consolidated level, we value the two segments separately. The Aerospace segment's Q1 FY27 EBITDA of ₹731mn, annualised (~₹2,924mn, ~₹292cr), is placed on an EV/EBITDA multiple reflecting genuine Tier-1 aerospace-manufacturing quality; the Consumer segment, currently loss-making, is assigned a smaller, speculative value reflecting optionality on management's own breakeven targets rather than current earnings:
| Component | Basis | Implied value (₹cr) |
|---|---|---|
| Aerospace segment | 26x annualised EBITDA (₹292cr) | 7,592 |
| Consumer segment | Indicative optionality value, not earnings-based | 700-1,000 |
| Combined indicative equity value | — | ~8,300-8,600 |
This combined estimate (~₹8,300-8,600cr) sits well below the current ₹15,155cr market cap, implying the market is already pricing in either a faster Consumer breakeven or further aerospace upside than this segment-based approach credits. Given the genuine, checkable positive trajectory (order book growth, credit-outlook improvement), we do not go as far as this gap implies and instead set our target modestly below CMP, reflecting balanced rather than strongly bearish uncertainty.
Upgrade triggers: Consumer segment reaching EBITDA breakeven ahead of or on schedule (Q4 FY27); a further CARE Ratings upgrade; aerospace order book continuing to compound at the current pace. Downgrade triggers: further delay to the Consumer ramp-up; a CARE outlook reversal back to Stable or Negative; any disclosed leverage increase without matching EBITDA growth.
| FY23 | FY24 | FY25 | FY26 | |
|---|---|---|---|---|
| Revenue | 812 | 965 | 938 | 1,285 |
| PBILDT | — | — | 97.6 | 146.5 |
| PAT | — | — | (102.4) | (113.3) |
| Gearing | — | — | 1.13x | 0.47x |
| Q1 FY27 segment detail (₹ mn) | Aerospace | Consumer |
|---|---|---|
| Revenue | 3,222 (+40% YoY) | 734 (+190% YoY) |
| EBITDA | 731 | (361) |
| Capacity utilisation | 70% (78% India) | 22% |
Source: CARE Ratings rationale (8 Jul 2026); Aequs Q1 FY27 press release and results (31 Jul 2026); screener.in (11 Sep 2026).
Dart Consultants is a market intelligence and technology service provider, not a SEBI-registered Investment Adviser or Research Analyst. This report is educational material only — not investment advice, and not a recommendation to buy or sell any stock. The HOLD rating above is an educational device for summarising public information, not a regulated recommendation, and reflects the genuinely short public track record of a company that only listed in December 2025. The analyst(s) hold no position in, and have no banking, advisory or brokerage relationship with, Aequs Limited, and have received no compensation from the company.
| 12-month target | ₹215 |
| CMP (11 Sep 2026) | ₹226 |
| Implied downside | (4.9)% |
| Rating | HOLD |
| Market cap | ₹15,155cr |
| P/E | not meaningful (loss-making) |
| Credit rating | CARE BBB-; Positive |
| Aerospace order book | >US$1.0bn (Jun 2026) |
| Promoter & group | 59.09% |
| Public | 38.62% |
| ESOP trust | 2.29% |
| Promoter shares locked in | 98.96% |
| FY25 | FY26 | |
|---|---|---|
| Revenue | 938 | 1,285 |
| PBILDT | 97.6 | 146.5 |
| PAT | (102.4) | (113.3) |
